De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
BLISSGVS Overzicht aandelen
Bliss GVS Pharma Limited ontwikkelt, produceert en verkoopt farmaceutische formuleringen in India en daarbuiten.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 4/6 |
| Toekomstige groei | 0/6 |
| Prestaties in het verleden | 4/6 |
| Financiële gezondheid | 6/6 |
| Dividenden | 3/6 |
Bliss GVS Pharma Limited Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | ₹138.86 |
| 52 Week Hoogtepunt | ₹149.60 |
| 52 Week Laag | ₹77.35 |
| Bèta | 0.96 |
| 11 maand verandering | 6.90% |
| 3 maanden verandering | 27.42% |
| 1 Jaar Verandering | 58.97% |
| 33 jaar verandering | 30.39% |
| 5 jaar verandering | -0.029% |
| Verandering sinds IPO | 241.60% |
Recent nieuws en updates
These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Safely
Aug 25
Bliss GVS Pharma Limited's (NSE:BLISSGVS) Prospects Need A Boost To Lift Shares
Aug 07Recent updates
These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Safely
Aug 25Bliss GVS Pharma Limited's (NSE:BLISSGVS) Prospects Need A Boost To Lift Shares
Aug 07Increases to Bliss GVS Pharma Limited's (NSE:BLISSGVS) CEO Compensation Might Cool off for now
Jul 19Bliss GVS Pharma's (NSE:BLISSGVS) Dividend Will Be ₹0.50
Jul 18Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50
Jul 04We Think Bliss GVS Pharma's (NSE:BLISSGVS) Solid Earnings Are Understated
May 10Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Right But Growth Is Lacking
Apr 27Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Feb 20There Is A Reason Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Undemanding
Jan 26Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Jul 14Bliss GVS Pharma (NSE:BLISSGVS) Has Affirmed Its Dividend Of ₹0.50
Sep 11Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50
Aug 28These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Reasonably Well
May 21Estimating The Intrinsic Value Of Bliss GVS Pharma Limited (NSE:BLISSGVS)
Apr 08A Look At Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Returns
Mar 18Here's How We Evaluate Bliss GVS Pharma Limited's (NSE:BLISSGVS) Dividend
Feb 25Bliss GVS Pharma (NSE:BLISSGVS) Has A Pretty Healthy Balance Sheet
Feb 08What Type Of Shareholders Make Up Bliss GVS Pharma Limited's (NSE:BLISSGVS) Share Registry?
Jan 21Do Its Financials Have Any Role To Play In Driving Bliss GVS Pharma Limited's (NSE:BLISSGVS) Stock Up Recently?
Jan 08How Is Bliss GVS Pharma's (NSE:BLISSGVS) CEO Paid Relative To Peers?
Dec 26
Did Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Deserve to Gain 14%?
Dec 13Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?
Nov 30Bliss GVS Pharma Limited (NSE:BLISSGVS) Insiders Increased Their Holdings
Nov 18Does Bliss GVS Pharma Limited (NSE:BLISSGVS) Have A Place In Your Dividend Portfolio?
Nov 06Is Bliss GVS Pharma (NSE:BLISSGVS) A Risky Investment?
Oct 25Is Bliss GVS Pharma Limited's (NSE:BLISSGVS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Oct 07How Much Is Bliss GVS Pharma Limited (NSE:BLISSGVS) CEO Getting Paid?
Sep 19Rendement voor aandeelhouders
| BLISSGVS | IN Pharmaceuticals | IN Markt | |
|---|---|---|---|
| 7D | 8.4% | -0.8% | -0.9% |
| 1Y | 59.0% | 60.3% | 39.7% |
Rendement versus industrie: BLISSGVS presteerde slechter dan de Indian Pharmaceuticals -sector, die het afgelopen jaar een rendement van 60.3 % opleverde.
Rendement versus markt: BLISSGVS overtrof de Indian markt, die het afgelopen jaar een rendement opleverde van 39.3 %.
Prijsvolatiliteit
| BLISSGVS volatility | |
|---|---|
| BLISSGVS Average Weekly Movement | 6.5% |
| Pharmaceuticals Industry Average Movement | 6.1% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.4% |
| 10% least volatile stocks in IN Market | 3.9% |
Stabiele aandelenkoers: BLISSGVS heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 6% ) van BLISSGVS is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1984 | 831 | Gagan Sharma | www.blissgvs.com |
Bliss GVS Pharma Limited ontwikkelt, produceert en verkoopt farmaceutische formuleringen in India en daarbuiten. Het bedrijf biedt farmaceutische producten aan, waaronder capsules, crèmes/gels/zalven, droog poeder voor injecties en orale suspensies, bruistabletten, oog-/oordruppels, injecties, vloeibare preparaten, zuigtabletten, neusoplossingen, orale vaste stoffen, parenterale middelen, pessaria, zakjes, zachte gelatine capsules, zetpillen, suspensies, lokale preparaten en transdermale pleisters. Het bedrijf levert ook andere gezondheidsproducten, zoals balsems, neusinhalatoren, receptvrije producten, vaseline, roll-ons, zepen, sprays en vaginale wasmiddelen.
Bliss GVS Pharma Limited Samenvatting
| BLISSGVS fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | ₹14.59b |
| Inkomsten(TTM) | ₹814.66m |
| Inkomsten(TTM) | ₹7.94b |
17.9x
Koers/Winstverhouding1.8x
P/S-verhoudingIs BLISSGVS overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| BLISSGVS resultatenrekening (TTM) | |
|---|---|
| Inkomsten | ₹7.94b |
| Kosten van inkomsten | ₹4.01b |
| Brutowinst | ₹3.93b |
| Overige uitgaven | ₹3.11b |
| Inkomsten | ₹814.66m |
Laatst gerapporteerde inkomsten
Jun 30, 2024
Volgende inkomensdatum
Oct 24, 2024
| Winst per aandeel (EPS) | 7.75 |
| Brutomarge | 49.47% |
| Nettowinstmarge | 10.26% |
| Schuld/Eigen Vermogen Verhouding | 10.0% |
Hoe presteerde BLISSGVS op de lange termijn?
Bekijk historische prestaties en vergelijking